These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2415766)

  • 1. [Prognostic value of studying indices of nonspecific resistance and humoral immunity in patients with erysipelas].
    Kriukova SA; Panichkina LN
    Lab Delo; 1985; (9):555-6. PubMed ID: 2415766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indicators of nonspecific resistance of the body in patients with erysipelas].
    Lipkovskaiia IV; Ermolin GA; Sokol AS; Pavlishin VV; Efremov AN
    Vrach Delo; 1989 Feb; (2):107-9. PubMed ID: 2711647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonspecific resistance of the body in erysipelas].
    Nagoev BS
    Sov Med; 1988; (4):25-7. PubMed ID: 3406817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic importance of determining the nonspecific resistance and allergy indices in erysipelas].
    Kriukova SA
    Vrach Delo; 1980 Apr; (4):107-9. PubMed ID: 6247841
    [No Abstract]   [Full Text] [Related]  

  • 5. [The information value of immunological tests in predicting recurrences of erysipelas].
    Bala MA; Rychnev VE; Tret'iakova NV
    Vrach Delo; 1990 Jun; (6):118-20. PubMed ID: 2399705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation].
    Elagina LV; Savchenko TV; Pavlova MV
    Klin Med (Mosk); 1998; 76(1):25-7. PubMed ID: 9532910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal antibodies in studying indices of cellular immunity in patients with erysipelas].
    Frolov VM; Gaĭdash IS; Peresadin NA; Baskakov IN
    Lab Delo; 1989; (6):71-2. PubMed ID: 2474717
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlations of cellular and humoral indices of immunity and nonspecific resistance in children with neurodermatitis].
    Gorlanov IA; Zver'kova FA; Kornisheva VG; Nazarov PG; Ostrovskiĭ AD
    Vestn Dermatol Venerol; 1987; (4):55-60. PubMed ID: 3604449
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of the indices of immunity for predicting the course and assessing the effectiveness of the treatment in acute suppurative lactation mastitis].
    Belokurov IuN; Gramenitskiĭ AB; Malafeeva EV; Aleksandrov IuK
    Vestn Khir Im I I Grek; 1985 Dec; 135(12):54-8. PubMed ID: 3832557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic aspects of erysipelas].
    Uzhinova EP; Gudina RV; Dovgaliuk TI
    Sov Med; 1986; (6):111-2. PubMed ID: 3750040
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of selenium-containing supplements on the indices of specific immunity and nonspecific resistance in chicken].
    Kovalenko MV; Stepchenko LM; Shevtsova AI; Brazaluk OZ; Suraĭ PF
    Fiziol Zh (1994); 2008; 54(1):69-73. PubMed ID: 18416187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of erysipelas. 3. Streptococcal vaccine treatment of relapsing erysipelas.
    Korossy S; Rajka O; Böszörményi J; Gózony M
    Acta Med Acad Sci Hung; 1968; 25(1):51-61. PubMed ID: 5678738
    [No Abstract]   [Full Text] [Related]  

  • 14. [The circulating immune complexes in erysipelas: diagnostic and prognostic significance].
    Frolov VM; Rychnev VE; Bala MA
    Lab Delo; 1986; (3):159-61. PubMed ID: 2421086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of serum antibodies in patients with recurrent erysipelas].
    Frolov VM; Rychnev VE; Zhuravleva NV
    Klin Med (Mosk); 1985 May; 63(5):91-5. PubMed ID: 4046519
    [No Abstract]   [Full Text] [Related]  

  • 16. [The status of body nonspecific resistance and humoral immunity in tobacco smoking].
    Zabrodskiĭ PF
    Voen Med Zh; 1987 Jul; (7):60-1. PubMed ID: 3672976
    [No Abstract]   [Full Text] [Related]  

  • 17. [Natural immunity factors as indices of body reaction to heliogeophysical effects].
    Gushchina LA
    Kosm Biol Aviakosm Med; 1982; 16(6):68-71. PubMed ID: 6217378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of the clinical course of erysipelas and various indicators of nonspecific resistance in middle-aged patients].
    Kriukova ZV; Panichkina LN; Kriukova SA
    Vestn Dermatol Venerol; 1984 Aug; (8):48-50. PubMed ID: 6485539
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circulating immune complexes in patients with erysipelas].
    Il'inskiĭ IuA; Druganina AA; Pogorel'skaia LV; Podgorodnichenko VK; Lisenkov AN
    Sov Med; 1986; (9):20-3. PubMed ID: 3798215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the pathogenesis of recurrent erysipelas].
    Pîrvu C; Serban I; Cîmpeanu M
    Med Interna (Bucur); 1969 Feb; 21(2):191-6. PubMed ID: 4180975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.